ACM
TMO icon

Aquatic Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Aquatic Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Sell
26,113
-3,276
-11% -$1.57M 0.45% 38
2026
Q1 		$14.4M Sell
29,389
-39,691
-57% -$21.5M 0.42% 49
2025
Q4 		$40M Sell
69,080
-30,631
-31% -$17.3M 1.14% 4
2025
Q3 		$48.4M Sell
99,711
-47,211
-32% -$22M 0.9% 10
2025
Q2 		$59.6M Buy
146,922
+67,090
+84% +$28.1M 1.2% 1
2025
Q1 		$39.7M Buy
79,832
+24,884
+45% +$13.5M 1.01% 7
2024
Q4 		$28.6M Buy
+54,948
New +$30.2M 0.77% 18
2024
Q3 		– Sell
-53,480
Closed -$29.6M – 1546
2024
Q2 		$29.6M Buy
53,480
+31,880
+148% +$18.3M 1.09% 17
2024
Q1 		$12.6M Sell
21,600
-7,760
-26% -$4.35M 0.41% 61
2023
Q4 		$15.6M Buy
29,360
+15,240
+108% +$7.38M 0.4% 66
2023
Q3 		$7.15M Sell
14,120
-14,680
-51% -$7.82M 0.3% 86
2023
Q2 		$15M Buy
28,800
+19,700
+216% +$10.6M 0.81% 26
2023
Q1 		$5.25M Sell
9,100
-1,300
-13% -$733K 0.32% 88
2022
Q4 		$5.73M Buy
10,400
+5,600
+117% +$2.97M 0.42% 50
2022
Q3 		$2.44M Buy
+4,800
New +$2.69M 0.24% 116
2022
Q1 		– Sell
-600
Closed -$400K – 1526
2021
Q4 		$400K Buy
+600
New +$375K 0.77% 6

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Aquatic Capital Management's TMO Position: Q2 2026 in Review

Aquatic Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $1.57M and leaving 26,113 shares worth $13.1M. The position accounts for 0.45% of the portfolio, ranked #38.

Aquatic Capital Management first reported a position in TMO in Q4 2021 and has held it in 16 quarters since. The position peaked at $59.6M in Q2 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Aquatic Capital Management held 26,113 shares of Thermo Fisher Scientific worth $13.1M as of Q2 2026.
  • Aquatic Capital Management sold 3,276 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.57M.
  • Thermo Fisher Scientific made up 0.45% of Aquatic Capital Management's portfolio in Q2 2026, its #38 holding.
  • Aquatic Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 16 quarters since.
  • Aquatic Capital Management's Thermo Fisher Scientific position peaked at $59.6M in Q2 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.